Cresco Labs(TSE:CL)
CA$0.60-0.06 (-9.09%)
TSE:CL
Cresco Labs financials statements
CA$0.60
At close:-0.06 (-9.09%)
Want to see TSE:CL full AI Analyst Report?
Cresco Labs (CL) Ratios
204 Followers
Cresco Labs Ratios
TSE:CL's free cash flow for Q3 2026 was $21.07M. For the 2026 fiscal year, TSE:CL's free cash flow was decreased by $-5.07M and operating cash flow was $26.14M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.59 | 3.12 | 1.39 | 1.16 | 1.46 |
| Quick Ratio | 1.60 | 2.24 | 0.85 | 0.68 | 0.99 |
| Cash Ratio | 0.91 | 1.46 | 0.52 | 0.42 | 0.78 |
| Solvency Ratio | -0.09 | -0.01 | -0.11 | -0.15 | -0.28 |
| Operating Cash Flow Ratio | 0.74 | 1.40 | 0.29 | 0.07 | 0.05 |
| Short-Term Operating Cash Flow Coverage | 9.91 | 14.21 | 5.97 | 1.97 | 1.49 |
| Net Current Asset Value | $ -684.28M | $ -672.92M | $ -652.31M | $ -669.96M | $ -560.97M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.49 | 0.47 | 0.50 | 0.42 | 0.35 |
| Debt-to-Equity Ratio | 1.72 | 1.35 | 1.35 | 1.07 | 0.83 |
| Debt-to-Capital Ratio | 0.63 | 0.57 | 0.57 | 0.52 | 0.45 |
| Long-Term Debt-to-Capital Ratio | 0.55 | 0.49 | 0.50 | 0.43 | 0.38 |
| Financial Leverage Ratio | 3.52 | 2.85 | 2.69 | 2.53 | 2.36 |
| Debt Service Coverage Ratio | -0.35 | 0.94 | -0.64 | -1.46 | -3.23 |
| Interest Coverage Ratio | 1.26 | 1.82 | -1.38 | -1.44 | -4.17 |
| Debt to Market Cap | 1.02 | 1.49 | 1.16 | 0.90 | 0.27 |
| Interest Debt Per Share | 1.89 | 2.02 | 2.30 | 2.44 | 2.58 |
| Net Debt to EBITDA | 24.19 | 4.39 | -41.45 | -51.65 | -2.51 |
| Profitability Margins | |||||
| Gross Profit Margin | 48.64% | 50.32% | 47.01% | 48.30% | 49.45% |
| EBIT Margin | -5.30% | 6.67% | -10.80% | -8.12% | -24.90% |
| EBITDA Margin | 3.05% | 15.78% | -1.81% | -1.27% | -19.43% |
| Operating Profit Margin | 11.53% | 14.81% | -11.39% | -10.00% | -26.45% |
| Pretax Profit Margin | -14.30% | -1.47% | -19.06% | -15.06% | -31.24% |
| Net Profit Margin | -20.65% | -10.28% | -22.77% | -25.16% | -38.90% |
| Continuous Operations Profit Margin | -20.99% | -8.35% | -23.33% | -25.61% | -36.13% |
| Net Income Per EBT | 144.39% | 701.19% | 119.48% | 167.09% | 124.49% |
| EBT Per EBIT | -124.01% | -9.89% | 167.27% | 150.55% | 118.12% |
| Return on Assets (ROA) | -11.53% | -5.49% | -12.92% | -13.39% | -17.95% |
| Return on Equity (ROE) | -40.54% | -15.68% | -34.71% | -33.82% | -42.30% |
| Return on Capital Employed (ROCE) | 7.03% | 8.51% | -7.58% | -6.47% | -14.57% |
| Return on Invested Capital (ROIC) | 6.88% | 8.35% | -7.45% | -6.37% | -14.18% |
| Return on Tangible Assets | -19.34% | -9.57% | -22.77% | -25.08% | -35.67% |
| Earnings Yield | -33.27% | -23.67% | -40.17% | -39.35% | -18.37% |
| Efficiency Ratios | |||||
| Receivables Turnover | 17.14 | 14.05 | 15.09 | 14.80 | 18.39 |
| Payables Turnover | 20.07 | 26.36 | 14.81 | 15.51 | 12.87 |
| Inventory Turnover | 3.36 | 4.32 | 3.79 | 3.24 | 3.04 |
| Fixed Asset Turnover | 1.56 | 1.59 | 1.59 | 1.66 | 1.80 |
| Asset Turnover | 0.56 | 0.53 | 0.57 | 0.53 | 0.46 |
| Working Capital Turnover Ratio | 3.72 | 5.22 | 12.53 | 9.44 | 5.47 |
| Cash Conversion Cycle | 111.81 | 96.66 | 95.84 | 113.90 | 111.57 |
| Days of Sales Outstanding | 21.30 | 25.98 | 24.18 | 24.66 | 19.85 |
| Days of Inventory Outstanding | 108.71 | 84.53 | 96.31 | 112.77 | 120.08 |
| Days of Payables Outstanding | 18.19 | 13.84 | 24.65 | 23.54 | 28.37 |
| Operating Cycle | 130.01 | 110.51 | 120.49 | 137.44 | 139.94 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.22 | 0.38 | 0.18 | 0.06 | 0.06 |
| Free Cash Flow Per Share | 0.11 | 0.32 | 0.00 | -0.23 | -0.31 |
| Dividend Paid and CapEx Coverage Ratio | 2.07 | 5.64 | 1.01 | 0.22 | 0.15 |
| Capital Expenditure Coverage Ratio | 2.07 | 5.64 | 1.01 | 0.22 | 0.15 |
| Operating Cash Flow Coverage Ratio | 0.13 | 0.21 | 0.09 | 0.03 | 0.02 |
| Operating Cash Flow to Sales Ratio | 0.11 | 0.18 | 0.08 | 0.02 | 0.02 |
| Free Cash Flow Yield | 9.28% | 34.66% | 0.16% | -12.51% | -4.75% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -2.90 | -4.14 | -2.49 | -2.54 | -5.44 |
| Price-to-Sales (P/S) Ratio | 0.62 | 0.43 | 0.57 | 0.64 | 2.12 |
| Price-to-Book (P/B) Ratio | 1.22 | 0.66 | 0.86 | 0.86 | 2.30 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 10.78 | 2.89 | 641.70 | -8.00 | -21.07 |
| Price-to-Operating Cash Flow Ratio | 5.58 | 2.37 | 7.46 | 28.75 | 120.11 |
| Price-to-Earnings Growth (PEG) Ratio | -0.03 | 0.07 | 0.10 | 0.06 | -0.01 |
| Enterprise Value Multiple | 44.54 | 7.15 | -72.72 | -102.19 | -13.41 |
| Enterprise Value | 906.25M | 816.57M | 1.02B | 1.09B | 2.14B |
| EV to EBITDA | 44.54 | 7.15 | -72.72 | -102.19 | -13.41 |
| EV to Sales | 1.36 | 1.13 | 1.32 | 1.29 | 2.61 |
| EV to Free Cash Flow | 23.59 | 7.49 | 1492.40 | -16.17 | -25.93 |
| EV to Operating Cash Flow | 12.22 | 6.16 | 17.35 | 58.15 | 147.80 |
| Tangible Book Value Per Share | -0.68 | -0.55 | -0.49 | -0.50 | -0.33 |
| Shareholders’ Equity Per Share | 1.00 | 1.37 | 1.56 | 2.10 | 2.88 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.47 | -4.70 | -0.22 | -0.70 | -0.16 |
| Revenue Per Share | 1.96 | 2.10 | 2.38 | 2.83 | 3.13 |
| Net Income Per Share | -0.40 | -0.22 | -0.54 | -0.71 | -1.22 |
| Tax Burden | 1.44 | 7.01 | 1.19 | 1.67 | 1.24 |
| Interest Burden | 2.70 | -0.22 | 1.76 | 1.86 | 1.25 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.35 | 0.32 | 0.36 | 0.07 | 0.05 |
| Stock-Based Compensation to Revenue | 0.02 | 0.02 | 0.02 | 0.03 | 0.03 |
| Income Quality | -0.54 | -2.19 | -0.33 | -0.09 | -0.05 |
Currency in USD

